Efficacy of L-PRF Against Deproteinized Bovine Mineralized Bone (DBBM)

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

September 15, 2023

Study Completion Date

April 17, 2024

Conditions
Patients with Posterior Maxillary Atrophy and Need for Sinus Lift Surgery to Allow Implant Placement
Interventions
PROCEDURE

Sinus lift augmentation with bone substitute (Bio-Oss)

A maxillary sinus lift augmentation was performed with a lateral window approach that was filled with a bone substitute (Bio-Oss®) and covered with a collagen membrane (Bio-Guide®).At 4 months after sinus lift, a biopsy was taken and implants (Starumann®) were placed with submerged healing. After 6 months, the second surgical phase was performed and another biopsy was taken. The bone samples collected were analyzed histologically and histomorphometrically.

PROCEDURE

Open sinus lift surgery lift using Platelet- and leukocyte-rich fibrin (L-PRF) mixed with a bone substitute (Bio-Oss®(Geistlich AG, Wolhusen, Switzerland)) - L-PRF Block

"A maxillary sinus lift augmentation was performed with a lateral window approach that was filled using Platelet- and leukocyte-rich fibrin (L-PRF) mixed with a bone substitute (Bio-Oss®) and covered with a collagen membrane (Bio-Guide®) (L-PRF block).~L-PRF block will be performed as described by Cortellini et al. 2018. L-PRF membranes are cut into small pieces and mixed with Bio-Oss® at a ratio of 2 membranes / 0.5 g biomaterial. Pieces of the block will be removed and compacted in the sinus cavity until it is filled.~At 4 months after sinus lift, a biopsy was taken and implants (Starumann®) were placed with submerged healing. After 6 months, the second surgical phase was performed and another biopsy was taken. The bone samples collected were analyzed histologically and histomorphometrically."

Trial Locations (1)

15782

Department of periodontology, Faculty of Dentistry, University of Santiago de Compostela, Santiago de Compostela

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Straumanngroup

UNKNOWN

collaborator

Geistlich Pharma AG

INDUSTRY

lead

University of Santiago de Compostela

OTHER

NCT06686836 - Efficacy of L-PRF Against Deproteinized Bovine Mineralized Bone (DBBM) | Biotech Hunter | Biotech Hunter